Myasthenia Gravis News, delivered by Bionews, is an online news source intended to provide the myasthenia gravis (MG) community with the most recent news and information about MG, as well as first-hand community perspectives from patient and caregiver columnists. This news feed features timely articles focused on a number of topics, including new MG research, patient and caregiver stories, new treatments and study outcomes, general MG management information, and helpful tips from across the MG community.
MGFA understands the value of this timely information to individuals living with MG, so we have partnered with Bionews to feature the Myasthenia Gravis News feed on the MGFA website. Now, visitors to myasthenia.org have direct access to the information and news stories delivered by Bionews.
You can find the news feed here or via the MG in the News page.
“Bionews, through Myasthenia Gravis News, is deeply committed to empowering the myasthenia gravis community,” said Brian Keigley, President of Bionews. “By partnering with the Myasthenia Gravis Foundation of America, we aim to enhance support for the MG community by broadening access to critical news and resources, promoting disease-specific events, and fostering a connected and supportive community for those affected by myasthenia gravis.”
All articles on Myasthenia Gravis News are original content produced by in-house Bionews writers and editors. In addition, a number of articles are written by people living with MG, who express hope in overcoming the challenges of the disease. These informative articles offer a source of opinions and perspectives about MG while highlighting new and evolving ways to treat and deal with the disease.
Occasionally, Bionews seeks the opinion of outside experts for interviews and Q&As, so source material is always up-to-date and based on the latest information.
Bionews is a digital health solutions company dedicated to empowering more than 50 rare disease communities with trusted information, news, and connections. Since 2013, they have been committed to serving patients and elevating their voices. Their motto is “For Rare, By Rare.”
Bionews offers a comprehensive platform serving a wide range of rare diseases, from larger, condition-specific communities including pulmonary fibrosis to smaller communities, such as AADC and myasthenia gravis.